Incidental Mutation 'IGL01380:Pak2'
ID 78807
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Pak2
Ensembl Gene ENSMUSG00000022781
Gene Name p21 (RAC1) activated kinase 2
Synonyms D16Ertd269e, PAK-2, 5330420P17Rik, A130002K10Rik
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # IGL01380
Quality Score
Status
Chromosome 16
Chromosomal Location 31835108-31898160 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to T at 31860362 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Valine to Glutamic Acid at position 167 (V167E)
Ref Sequence ENSEMBL: ENSMUSP00000023467 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000023467]
AlphaFold Q8CIN4
Predicted Effect probably benign
Transcript: ENSMUST00000023467
AA Change: V167E

PolyPhen 2 Score 0.039 (Sensitivity: 0.94; Specificity: 0.83)
SMART Domains Protein: ENSMUSP00000023467
Gene: ENSMUSG00000022781
AA Change: V167E

DomainStartEndE-ValueType
low complexity region 58 70 N/A INTRINSIC
PBD 74 109 4.83e-16 SMART
low complexity region 170 177 N/A INTRINSIC
low complexity region 212 226 N/A INTRINSIC
S_TKc 249 500 9.34e-97 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000125019
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. [provided by RefSeq, Jul 2008]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit lethality between E8 and the postnatal period with prominent head folds, impaired somite development, and growth retardation. Mice homozygous for a knock-in allele exhibit increased cell proliferation and decreased apoptosis. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 61 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Aadacl2fm1 A G 3: 59,840,053 (GRCm39) T42A probably benign Het
Abcc10 C A 17: 46,634,948 (GRCm39) V352L possibly damaging Het
Ankrd44 A T 1: 54,766,724 (GRCm39) M488K probably benign Het
Ano8 A G 8: 71,933,453 (GRCm39) probably benign Het
Atp2a1 T A 7: 126,047,942 (GRCm39) M623L possibly damaging Het
Atxn10 G T 15: 85,260,896 (GRCm39) E214* probably null Het
Btla A C 16: 45,070,716 (GRCm39) D225A probably benign Het
C030048H21Rik G A 2: 26,146,659 (GRCm39) Q1218* probably null Het
Cacna1a A G 8: 85,285,746 (GRCm39) Y750C probably damaging Het
Ccdc15 A T 9: 37,187,853 (GRCm39) probably benign Het
Ccdc18 T A 5: 108,328,753 (GRCm39) I724N probably damaging Het
Cluh T A 11: 74,556,772 (GRCm39) F937L probably benign Het
Clybl G T 14: 122,616,761 (GRCm39) A259S probably benign Het
Cyp4f39 T G 17: 32,700,832 (GRCm39) I167S probably damaging Het
Dchs1 T A 7: 105,411,418 (GRCm39) D1566V probably damaging Het
Dnah3 C T 7: 119,525,787 (GRCm39) A3867T probably damaging Het
Dtwd1 T A 2: 126,001,847 (GRCm39) L189Q probably benign Het
Dusp10 T C 1: 183,801,211 (GRCm39) I326T possibly damaging Het
Eaf1 T A 14: 31,219,767 (GRCm39) probably benign Het
Eif3c C T 7: 126,163,585 (GRCm39) probably benign Het
Fam169a C T 13: 97,228,459 (GRCm39) T44M probably damaging Het
Fam184a T C 10: 53,570,782 (GRCm39) probably benign Het
Fam25a C T 14: 34,075,655 (GRCm39) A46T probably null Het
Gckr A G 5: 31,456,977 (GRCm39) probably benign Het
Gfra2 G T 14: 71,204,586 (GRCm39) probably benign Het
Gm8237 A T 14: 5,863,703 (GRCm38) probably null Het
H2-Eb2 G T 17: 34,554,783 (GRCm39) L228F probably benign Het
Igf2r T C 17: 12,914,261 (GRCm39) N1736S probably benign Het
Izumo1 T G 7: 45,276,519 (GRCm39) S361A probably benign Het
Klri1 T C 6: 129,675,761 (GRCm39) I170V probably benign Het
L3mbtl2 C T 15: 81,555,326 (GRCm39) A193V possibly damaging Het
Lats1 T A 10: 7,567,544 (GRCm39) M105K possibly damaging Het
Lrpprc T C 17: 85,030,158 (GRCm39) D1080G probably benign Het
Lrrc74a A T 12: 86,808,496 (GRCm39) M425L possibly damaging Het
Mfsd13a G T 19: 46,356,347 (GRCm39) D151Y probably damaging Het
Mst1 G A 9: 107,961,787 (GRCm39) E640K probably damaging Het
Napsa T C 7: 44,236,098 (GRCm39) V379A probably damaging Het
Or1e16 A T 11: 73,286,017 (GRCm39) M277K probably damaging Het
Or55b4 C T 7: 102,133,592 (GRCm39) C245Y probably damaging Het
Or7c19 C A 8: 85,957,775 (GRCm39) S217Y probably damaging Het
Or7c19 A T 8: 85,957,958 (GRCm39) Y278F possibly damaging Het
Otop3 T C 11: 115,237,237 (GRCm39) V567A probably damaging Het
Oxsr1 A T 9: 119,089,167 (GRCm39) probably benign Het
Pcdhb16 A G 18: 37,612,498 (GRCm39) H486R probably benign Het
Plekha5 C T 6: 140,516,042 (GRCm39) probably benign Het
Rbm6 T C 9: 107,665,548 (GRCm39) D616G probably damaging Het
Sf3b1 T C 1: 55,027,108 (GRCm39) Y1249C probably damaging Het
Sipa1l3 T C 7: 29,030,797 (GRCm39) H534R possibly damaging Het
Slco1c1 T C 6: 141,485,777 (GRCm39) Y136H probably damaging Het
Smarca4 A G 9: 21,590,369 (GRCm39) M1333V probably benign Het
Smc4 A G 3: 68,933,161 (GRCm39) D54G probably damaging Het
Spag5 T A 11: 78,195,443 (GRCm39) V250E possibly damaging Het
Stxbp4 A G 11: 90,512,475 (GRCm39) probably benign Het
Suv39h2 T A 2: 3,465,296 (GRCm39) probably benign Het
Taar8b T A 10: 23,968,005 (GRCm39) H63L probably damaging Het
Tex2 G A 11: 106,435,141 (GRCm39) Q264* probably null Het
Thnsl2 A C 6: 71,115,740 (GRCm39) S156A probably benign Het
Tmtc4 G T 14: 123,163,366 (GRCm39) probably benign Het
Usp25 T C 16: 76,890,566 (GRCm39) L758P probably benign Het
Zfyve1 G A 12: 83,599,281 (GRCm39) R144C probably damaging Het
Zpld1 A G 16: 55,072,133 (GRCm39) V42A probably damaging Het
Other mutations in Pak2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01807:Pak2 APN 16 31,856,097 (GRCm39) missense probably damaging 0.99
IGL02296:Pak2 APN 16 31,862,820 (GRCm39) critical splice acceptor site probably null
IGL02828:Pak2 APN 16 31,840,674 (GRCm39) missense probably damaging 1.00
K7371:Pak2 UTSW 16 31,852,602 (GRCm39) splice site probably benign
PIT4142001:Pak2 UTSW 16 31,841,930 (GRCm39) missense probably damaging 1.00
R0077:Pak2 UTSW 16 31,852,661 (GRCm39) missense possibly damaging 0.93
R1569:Pak2 UTSW 16 31,856,113 (GRCm39) missense probably damaging 1.00
R4179:Pak2 UTSW 16 31,871,005 (GRCm39) missense probably benign 0.02
R4180:Pak2 UTSW 16 31,871,005 (GRCm39) missense probably benign 0.02
R4223:Pak2 UTSW 16 31,871,028 (GRCm39) missense probably benign
R5114:Pak2 UTSW 16 31,861,936 (GRCm39) intron probably benign
R5294:Pak2 UTSW 16 31,840,648 (GRCm39) missense probably damaging 0.99
R5340:Pak2 UTSW 16 31,853,764 (GRCm39) splice site probably null
R5342:Pak2 UTSW 16 31,863,306 (GRCm39) missense probably damaging 1.00
R5586:Pak2 UTSW 16 31,860,337 (GRCm39) missense probably benign 0.00
R7590:Pak2 UTSW 16 31,871,014 (GRCm39) missense probably benign 0.27
R7995:Pak2 UTSW 16 31,846,590 (GRCm39) missense possibly damaging 0.92
R8324:Pak2 UTSW 16 31,871,029 (GRCm39) missense probably benign 0.00
R8485:Pak2 UTSW 16 31,871,083 (GRCm39) missense probably benign 0.16
R8948:Pak2 UTSW 16 31,852,729 (GRCm39) splice site probably benign
R9723:Pak2 UTSW 16 31,852,650 (GRCm39) missense probably damaging 0.99
Z1177:Pak2 UTSW 16 31,863,396 (GRCm39) missense probably benign 0.08
Posted On 2013-11-05